| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DX04 | B | Valsartan - 51mg, Sacubitril - 49mg | 8448 | 164315/1 | ENTRESTO | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Farma SpA | Italy | 6,029,821 L.L | 23.08 | B | Novartis Pharma AG | Switzerland | 3/11/202 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DX04 | G | Sacubitril - 49mg, Valsartan - 51mg | 12473 | 100925/1 | VALBITRYL 49/51 | 60 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 5,490,557 L.L | 23.08 | B | 3/11/202 |

